Crude native Hapten-based indirect ELISA assay KIT and lyophilised controls for the confirmatory diagnosis of bovine brucellosis in blood serum and milk by animal and tank
OwnerVictoria Maroun Cortezinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerVictoria Maroun Cortezinventor
Estimating the term…
A diagnostic kit for a confirmatory assay using the indirect ELISA method that measures the levels of anti-Native Hapten antibodies produced during a real infection, thereby preventing large financial losses to livestock farm, by discerning “false positives” that present anti-LPS antibodies due to cross-reactions with enterobacteria and post-vaccinal antibodies for the diagnosis of bovine brucellosis in blood serum and individual milk (per animal) and bulk milk (tank), characterised by using the crude Native Hapten antigen, extracted from B. melitensis 16M strain, with no purification treatment and an effective adherence capacity, which is used to antigenize plates at a known concentration (1 μg per well), where using as reference positive and negative controls subjected to the lyophilisation (freeze drying) method to ensure their preservation, thereby avoiding the contamination and degradation of the antibodies present and ensuring the stability of the optical densities in said controls for a correct results interpretation of an indirect ELISA, are taken as reference. The lyophilisation method for controls that may be used in other diagnostic methods is also presented.
Indirect ELISA test procedure to detect antibodies anti Native Hapten for confirmatory diagnosis of bovine brucellosis in blood serum and individual milk (per animal) and bulk milk (tank) with a detection capacity of 969,162 liters of positive milk in a 30,000-liter tank, wherein the antigen Native Hapten is crude Native Hapten, which is obtained by the next procedure of extraction with ethanol from B. melitensis 16M strain, with no further purification treatment:
Dependencies are inferred from the claim text.